» Articles » PMID: 32781640

Combination of Peri-Tumoral and Intra-Tumoral Radiomic Features on Bi-Parametric MRI Accurately Stratifies Prostate Cancer Risk: A Multi-Site Study

Abstract

Prostate cancer (PCa) influences its surrounding habitat, which tends to manifest as different phenotypic appearances on magnetic resonance imaging (MRI). This region surrounding the PCa lesion, or the peri-tumoral region, may encode useful information that can complement intra-tumoral information to enable better risk stratification. : To evaluate the role of peri-tumoral radiomic features on bi-parametric MRI (T2-weighted and Diffusion-weighted) to distinguish PCa risk categories as defined by D'Amico Risk Classification System. : We studied a retrospective, HIPAA-compliant, 4-institution cohort of 231 PCa patients ( = 301 lesions) who underwent 3T multi-parametric MRI prior to biopsy. PCa regions of interest (ROIs) were delineated on MRI by experienced radiologists following which peri-tumoral ROIs were defined. Radiomic features were extracted within the intra- and peri-tumoral ROIs. Radiomic features differentiating low-risk from: (1) high-risk (L-vs.-H), and (2) (intermediate- and high-risk (L-vs.-I + H)) lesions were identified. Using a multi-institutional training cohort of 151 lesions (D1, 116 patients), machine learning classifiers were trained using peri- and intra-tumoral features individually and in combination. The remaining 150 lesions (D2, 115 patients) were used for independent hold-out validation and were evaluated using Receiver Operating Characteristic (ROC) analysis and compared with PI-RADS v2 scores. : Validation on D2 using peri-tumoral radiomics alone resulted in areas under the ROC curve (AUCs) of 0.84 and 0.73 for the L-vs.-H and L-vs.-I + H classifications, respectively. The best combination of intra- and peri-tumoral features resulted in AUCs of 0.87 and 0.75 for the L-vs.-H and L-vs.-I + H classifications, respectively. This combination improved the risk stratification results by 3-6% compared to intra-tumoral features alone. Our radiomics-based model resulted in a 53% accuracy in differentiating L-vs.-H compared to PI-RADS v2 (48%), on the validation set. : Our findings suggest that peri-tumoral radiomic features derived from prostate bi-parametric MRI add independent predictive value to intra-tumoral radiomic features for PCa risk assessment.

Citing Articles

Evaluating the feasibility of AI-predicted bpMRI image features for predicting prostate cancer aggressiveness: a multi-center study.

Wang K, Luo N, Sun Z, Zhao X, She L, Xing Z Insights Imaging. 2025; 16(1):20.

PMID: 39812752 PMC: 11735704. DOI: 10.1186/s13244-024-01865-8.


Interpretable machine learning model for predicting clinically significant prostate cancer: integrating intratumoral and peritumoral radiomics with clinical and metabolic features.

Zhao W, Hou M, Wang J, Song D, Niu Y BMC Med Imaging. 2024; 24(1):353.

PMID: 39736623 PMC: 11684284. DOI: 10.1186/s12880-024-01548-2.


CT-based habitat radiomics for predicting treatment response to neoadjuvant chemoimmunotherapy in esophageal cancer patients.

Kong W, Xu J, Huang Y, Zhu K, Yao L, Wu K Front Oncol. 2024; 14:1418252.

PMID: 39691599 PMC: 11649542. DOI: 10.3389/fonc.2024.1418252.


Unveiling Tim-3 immune checkpoint expression in hepatocellular carcinoma through abdominal contrast-enhanced CT habitat radiomics.

Tang Z, Wang W, Gao B, Liu X, Liu X, Zhuo Y Front Oncol. 2024; 14:1456748.

PMID: 39582537 PMC: 11581969. DOI: 10.3389/fonc.2024.1456748.


Radiomic Pipelines for Prostate Cancer in External Beam Radiation Therapy: A Review of Methods and Future Directions.

Mendes B, Domingues I, Santos J J Clin Med. 2024; 13(13).

PMID: 38999473 PMC: 11242211. DOI: 10.3390/jcm13133907.


References
1.
Parmar C, Grossmann P, Bussink J, Lambin P, Aerts H . Machine Learning methods for Quantitative Radiomic Biomarkers. Sci Rep. 2015; 5:13087. PMC: 4538374. DOI: 10.1038/srep13087. View

2.
Partin A, Yoo J, Carter H, Pearson J, Chan D, Epstein J . The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer. J Urol. 1993; 150(1):110-4. DOI: 10.1016/s0022-5347(17)35410-1. View

3.
Beig N, Khorrami M, Alilou M, Prasanna P, Braman N, Orooji M . Perinodular and Intranodular Radiomic Features on Lung CT Images Distinguish Adenocarcinomas from Granulomas. Radiology. 2018; 290(3):783-792. PMC: 6394783. DOI: 10.1148/radiol.2018180910. View

4.
Greer M, Shih J, Lay N, Barrett T, Bittencourt L, Borofsky S . Interreader Variability of Prostate Imaging Reporting and Data System Version 2 in Detecting and Assessing Prostate Cancer Lesions at Prostate MRI. AJR Am J Roentgenol. 2019; 212(6):1197-1205. PMC: 8268760. DOI: 10.2214/AJR.18.20536. View

5.
Shiradkar R, Ghose S, Jambor I, Taimen P, Ettala O, Purysko A . Radiomic features from pretreatment biparametric MRI predict prostate cancer biochemical recurrence: Preliminary findings. J Magn Reson Imaging. 2018; 48(6):1626-1636. PMC: 6222024. DOI: 10.1002/jmri.26178. View